Bioiberica to Present Products for Joint and Tendon Health
05.14.18
New evidence for the therapeutic potential of chondroitin sulfate and glucosamine in muscle injuries will also be presented.
BoothF50
Bioiberica will present two food supplements for joint and tendon health.
Articolageno Caps is an innovative formula combining b-2cool and Mobilee (two Bioiberica joint health branded ingredients), along with vitamins, in a single product. b-2cool is a native type II collagen-based natural ingredient that helps maintain joint health thanks to its immune-mediated mechanism of action. Meanwhile, Mobilee is a patented ingredient rich in hyaluronic acid, which contributes to maintain joint function.
“The presentation at Vitafoods of this new product, planned to launch at the end of the year, is a major opportunity to promote our dedicated joint health and mobility range of nutritional ingredients and supplements. We remain committed to quality products based on innovation and scientific evidence,” said Bioiberica Human Health International Director Jaume Reguant.
In addition, the benefits of Tendoactive—a food supplement specific for tendons that contains type I hydrolysed collagen, mucopolysaccharides, vitamin C and manganese—will be presented. Marta Masides, head of product support at the Bioiberica R&D department, will give a talk titled “Innovative Approach to Tendon Health” at the Sports Nutrition Zone Theatre (May 16, 12:20 pm). Different scientific studies have shown that oral supplements in the form of Tendoactive represent a new approach to supporting tendon health from a nutritional perspective and as a complement to physical therapy.
The company will also present a scientific paper in the Posters Area on the therapeutic potential of chondroitin sulphate and glucosamine in muscle injuries, a preclinical study in human muscle cells, which clarifies the action mechanisms involved in the positive effects of pharmaceutical-grade chondroitin sulphate and glucosamine.
Bioiberica is a global company specializing in the research, production and sale of biomolecules such as chondroitin sulphate, glucosamine, heparin and hyaluronic acid. Since 1975, Bioiberica has consolidated its position as an international leader in joint health and chondroprotection through constant dedication and commitment to science and research. Vertically integrated from active ingredient to final product, Bioiberica places all its medical, scientific, and marketing knowledge at the client’s disposal for joint market development.
Bioiberica will present two food supplements for joint and tendon health.
Articolageno Caps is an innovative formula combining b-2cool and Mobilee (two Bioiberica joint health branded ingredients), along with vitamins, in a single product. b-2cool is a native type II collagen-based natural ingredient that helps maintain joint health thanks to its immune-mediated mechanism of action. Meanwhile, Mobilee is a patented ingredient rich in hyaluronic acid, which contributes to maintain joint function.
“The presentation at Vitafoods of this new product, planned to launch at the end of the year, is a major opportunity to promote our dedicated joint health and mobility range of nutritional ingredients and supplements. We remain committed to quality products based on innovation and scientific evidence,” said Bioiberica Human Health International Director Jaume Reguant.
In addition, the benefits of Tendoactive—a food supplement specific for tendons that contains type I hydrolysed collagen, mucopolysaccharides, vitamin C and manganese—will be presented. Marta Masides, head of product support at the Bioiberica R&D department, will give a talk titled “Innovative Approach to Tendon Health” at the Sports Nutrition Zone Theatre (May 16, 12:20 pm). Different scientific studies have shown that oral supplements in the form of Tendoactive represent a new approach to supporting tendon health from a nutritional perspective and as a complement to physical therapy.
The company will also present a scientific paper in the Posters Area on the therapeutic potential of chondroitin sulphate and glucosamine in muscle injuries, a preclinical study in human muscle cells, which clarifies the action mechanisms involved in the positive effects of pharmaceutical-grade chondroitin sulphate and glucosamine.
Bioiberica is a global company specializing in the research, production and sale of biomolecules such as chondroitin sulphate, glucosamine, heparin and hyaluronic acid. Since 1975, Bioiberica has consolidated its position as an international leader in joint health and chondroprotection through constant dedication and commitment to science and research. Vertically integrated from active ingredient to final product, Bioiberica places all its medical, scientific, and marketing knowledge at the client’s disposal for joint market development.
